(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

N NEXT & BIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

N NEXT & BIO

ST13

US500000098259147

Class

1, 5, 42, 44

Filing

98259147

Registration

7954437

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

04/03/2026

Trademark type

Combined

Nice classes

1, 5, 42, 44

Filing date

11/07/2023

Registration date

09/23/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/23/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

3

Owner type

03

Owner location

SEJONG-SI, KR

Examiner

MEBANE, ANASTASIA XAVIERA

Law office

O20

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the words "NEXT & BIO" in dark blue lettering to the right of a circle with the lower left half of the circle being dark blue and the upper right half of the circle being light blue. A white capital letter "N" is inside the circle.

Holders and representatives

Holders

KOLMAR HOLDINGS CO., LTD.
KOLMAR KOREA HOLDINGS CO., LTD.

Representatives

James J. Saul FAEGRE DRINKER BIDDLE & REATH LLP

Technical classification

Nice Classes

Class 1Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biological preparations for use in industry and scienceother than for medical or veterinary purposes; cells for scientific or laboratory purposes; cultures of microorganisms for scientific or laboratory purposesother than for medical and veterinary use; preparations of microorganismsother than for medical and veterinary use; bacterial preparationsother than for medical and veterinary use; bacteria for use in food manufacture; probiotic bacterial cultures for use in the manufacture of food supplements in the food industry; diagnostic reagentsother than for medical or veterinary purposes; reagents for medical research; chemical preparations in the nature of chemical additives for use in the manufacture of pharmaceuticals

Class 5

Biological preparations for use in cell cultures for medical purposesfor use in biotechnology for the treatment of cancerinfectious diseasesmetabolic diseases and disorders; vaccines; reagents for medical use; medical diagnostic reagents; diagnostic preparations for medical purposes; pharmaceutical preparations for diagnosis for medical purposes; chemico-pharmaceutical preparations for the treatment of central nervous system diseasescancer and metabolic diseases; chemico-pharmaceutical preparationschemical preparations for pharmaceutical or medical purposes; nutritional supplements; Veterinary preparations and substances for treating infections and inflammation; vitamin drops

Class 42

Development of biologics; scientific research in the field of pharmacy; scientific research in the fields of medicinehealth and pharmacology; scientific research and testing services in the nature of chemical screening analysis for drug discovery for scientific research purposes; Platform as a Service featuring computer software platforms for screening new pharmaceuticals and precision medicine; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; medical research laboratory services; Software as a service featuring software for analyzing datadatabase managementaccounting related to drug discovery; Platform as a Service featuring software for analyzing datadatabase managementaccounting in the fields of medicinehealth and pharmacology

Class 44

Medical analysis services for the diagnosis of cancer; medical servicesanalysis of human tissues for medical treatment; medical analysis for the diagnosis and treatment of persons; medical servicesanalysis of human biodata for medical purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; medical examination services; information services relating to medical products for treatment and medical purposes; medical information

Publications

History of USPTO decisions and trademark events.

33 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/23/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

09/23/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/05/2025

PUBO

PUBLISHED FOR OPPOSITION

08/05/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/30/2025

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

07/04/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/16/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/15/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/15/2025

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

04/15/2025

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

03/23/2025

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

02/10/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/10/2024

ALIE

ASSIGNED TO LIE

12/10/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

11/03/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/03/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

11/03/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/03/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/03/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

07/21/2024

GNSL

LETTER OF SUSPENSION E-MAILED

07/21/2024

CNSL

SUSPENSION LETTER WRITTEN

07/21/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/10/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/10/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/10/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

06/06/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/12/2024

GNRT

NON-FINAL ACTION E-MAILED

03/12/2024

CNRT

NON-FINAL ACTION WRITTEN

03/12/2024

DOCK

ASSIGNED TO EXAMINER

02/24/2024

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

12/07/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/06/2023

NWAP

NEW APPLICATION ENTERED

11/10/2023

Continuous trademark protection

Get notified about every new filing that threatens N NEXT & BIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.